Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
BLFS similar filings
- 9 Aug 22 BioLife Solutions Reports Second Quarter 2022 Financial Results and Updates Full Year 2022 Revenue Guidance
- 15 Jun 22 Submission of Matters to a Vote of Security Holders
- 9 May 22 BioLife Solutions Reports First Quarter 2022 Financial Results
- 7 Apr 22 Changes in Registrant's Certifying Accountant
- 18 Mar 22 BioLife Solutions Receives Nasdaq Notice of Noncompliance for Delayed 10-K Filing
- 28 Feb 22 BioLife Solutions Reports Unaudited Fourth Quarter and Full Year 2021 Financial Results
- 10 Jan 22 BioLife Solutions Announces Preliminary 2021 Revenue of $119 Million, Up 148% Over 2020
Filing view
External links
Exhibit 16.1
April 7, 2022
Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549
We have been furnished with a copy of the response to Item 4.01 of Form 8-K for the event that occurred on April 2, 2022, to be filed by our former client, BioLife Solutions, Inc. We agree with the statements made in response to that Item insofar as they relate to our Firm.
Very truly yours,
/s/ BDO USA, LLP